Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Ik Kim

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Clinical Nuclear Medicine|January 6, 2023
Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancerJunhwan Kim, Joonhyung Gil, Se Ik Kim, et al.
Frontiers in Oncology|July 5, 2022
Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South KoreaHyunA Jo, Se Ik Kim, Wenyu Wang, et al.
Journal of Immunology Research|July 23, 2014
Impact of underweight after treatment on prognosis of advanced-stage ovarian cancerSe Ik Kim, Hee Seung Kim, Tae Hun Kim, et al.
Journal of Korean Medical Science|November 6, 2015
Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen UseSe Ik Kim, Yumi Lee, Yedong Son, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 6, 2015
Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissectionSe Ik Kim, Myong Cheol Lim, Jeong Seon Lee, et al.
Journal of Gynecologic Oncology|January 9, 2026
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE)Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi, et al.
Anticancer Research|November 4, 2021
Ideal Nozzle Position During Pressurized Intraperitoneal Aerosol Chemotherapy in an <i>Ex Vivo</i> ModelJinlan Piao, Soo Jin Park, Heesu Lee, et al.
Molecular & Cellular Proteomics : MCP|January 20, 2023
Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian CarcinomaSe Ik Kim, Suhyun Hwangbo, Kisoon Dan, et al.
Microbiome|April 21, 2026
Trimethylamine-producing microbe Bacillus megaterium KCTC 3007 promotes antitumor immunity in endometrial cancer via type I interferon response pathwaysKyungchan Min, Se Ik Kim, Minji Lee, et al.
Cancers|March 28, 2026
Correction: Ahn et al. Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer Detection. <i>Cancers</i> 2025, <i>17</i>, 1251Eunyong Ahn, Se Ik Kim, Sungmin Park, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Clinical Nuclear Medicine|January 6, 2023
Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancerJunhwan Kim, Joonhyung Gil, Se Ik Kim, et al.
Frontiers in Oncology|July 5, 2022
Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South KoreaHyunA Jo, Se Ik Kim, Wenyu Wang, et al.
Journal of Immunology Research|July 23, 2014
Impact of underweight after treatment on prognosis of advanced-stage ovarian cancerSe Ik Kim, Hee Seung Kim, Tae Hun Kim, et al.
Journal of Korean Medical Science|November 6, 2015
Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen UseSe Ik Kim, Yumi Lee, Yedong Son, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 6, 2015
Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissectionSe Ik Kim, Myong Cheol Lim, Jeong Seon Lee, et al.
Journal of Gynecologic Oncology|January 9, 2026
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE)Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi, et al.
Anticancer Research|November 4, 2021
Ideal Nozzle Position During Pressurized Intraperitoneal Aerosol Chemotherapy in an <i>Ex Vivo</i> ModelJinlan Piao, Soo Jin Park, Heesu Lee, et al.
Molecular & Cellular Proteomics : MCP|January 20, 2023
Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian CarcinomaSe Ik Kim, Suhyun Hwangbo, Kisoon Dan, et al.
Microbiome|April 21, 2026
Trimethylamine-producing microbe Bacillus megaterium KCTC 3007 promotes antitumor immunity in endometrial cancer via type I interferon response pathwaysKyungchan Min, Se Ik Kim, Minji Lee, et al.
Cancers|March 28, 2026
Correction: Ahn et al. Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer Detection. <i>Cancers</i> 2025, <i>17</i>, 1251Eunyong Ahn, Se Ik Kim, Sungmin Park, et al.
Pageof 14